Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sparano, JA
   Clinical aspects and management of AIDS-related lymphoma
   EUROPEAN JOURNAL OF CANCER
   
   J.A. Sparano, "Clinical aspects and management of AIDS-related lymphoma", EUR J CANC, 37(10), 2001, pp. 1296-1305
2. Sparano, JA; Malik, U; Rajdev, L; Sarta, C; Hopkins, U; Wolff, AC
   Phase I trial of pegylated liposomal doxorubicin and docetaxel in advancedbreast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.A. Sparano et al., "Phase I trial of pegylated liposomal doxorubicin and docetaxel in advancedbreast cancer", J CL ONCOL, 19(12), 2001, pp. 3117-3125
3. Sparano, JA; Winer, EP
   Liposomal anthracyclines for breast cancer
   SEMINARS IN ONCOLOGY
   
   J.A. Sparano e E.P. Winer, "Liposomal anthracyclines for breast cancer", SEMIN ONCOL, 28(4), 2001, pp. 32-40
4. Sparano, JA
   Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials
   SEMINARS IN ONCOLOGY
   
   J.A. Sparano, "Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials", SEMIN ONCOL, 28(1), 2001, pp. 20-27
5. Ambinder, RF; Sparano, JA
   Primary central nervous system lymphoma
   HIV & HTLV-I ASSOCIATED MALIGNANCIES
   
   R.F. Ambinder e J.A. Sparano, "Primary central nervous system lymphoma", CANC TREAT, 104, 2001, pp. 231-246
6. Sparano, JA; Kalkut, G
   Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer
   HIV & HTLV-I ASSOCIATED MALIGNANCIES
   
   J.A. Sparano e G. Kalkut, "Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer", CANC TREAT, 104, 2001, pp. 347-366
7. Zafonte, BT; Hulit, J; Amanatullah, DF; Albanese, C; Wang, CG; Rosen, E; Reutens, A; Sparano, JA; Lisanti, MP; Pestell, RG
   Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle
   FRONTIERS IN BIOSCIENCE
   
   B.T. Zafonte et al., "Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle", FRONT BIOSC, 5, 2000, pp. D938-D961
8. Sparano, JA; Rajdev, L
   Taxane-based therapy for breast cancer: Combination or sequential therapy?
   CANCER INVESTIGATION
   
   J.A. Sparano e L. Rajdev, "Taxane-based therapy for breast cancer: Combination or sequential therapy?", CANCER INV, 18(5), 2000, pp. 498-500
9. Sparano, JA; O'Neill, A; Schaefer, PL; Falkson, CI; Wood, WC
   Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.A. Sparano et al., "Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196", J CL ONCOL, 18(12), 2000, pp. 2369-2377
10. Sparano, JA; Wolff, AC; Brown, D
    Troponins for predicting cardiotoxicity from cancer therapy
    LANCET
    
    J.A. Sparano et al., "Troponins for predicting cardiotoxicity from cancer therapy", LANCET, 356(9246), 2000, pp. 1947-1948
11. Sparano, JA; Anand, K; Desai, J; Mitnick, RJ; Kalkut, GE; Hanau, LH
    Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    
    J.A. Sparano et al., "Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center", J ACQ IMM D, 21, 1999, pp. S18-S22
12. Sparano, JA; Speyer, J; Gradishar, WJ; Liebes, L; Sridhara, R; Mendoza, S; Fry, D; Egorin, MJ
    Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    J.A. Sparano et al., "Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer", J CL ONCOL, 17(3), 1999, pp. 880-886
13. Sparano, JA; Hu, P; Rao, RM; Falkson, CI; Wolff, AC; Wood, WC
    Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study
    JOURNAL OF CLINICAL ONCOLOGY
    
    J.A. Sparano et al., "Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study", J CL ONCOL, 17(12), 1999, pp. 3828-3834
14. Racevskis, J; Dill, A; Sparano, JA; Ruan, HD
    Molecular cloning of LMO4, a new human LIM domain gene
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    
    J. Racevskis et al., "Molecular cloning of LMO4, a new human LIM domain gene", BBA-GENE ST, 1445(1), 1999, pp. 148-153
15. Sparano, JA
    Doxorubicin/taxane combinations: Cardiac toxicity and pharmacokinetics
    SEMINARS IN ONCOLOGY
    
    J.A. Sparano, "Doxorubicin/taxane combinations: Cardiac toxicity and pharmacokinetics", SEMIN ONCOL, 26(3), 1999, pp. 14-19
16. Desai, J; Mitnick, RJ; Henry, DH; Llena, J; Sparano, JA
    Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma
    CANCER
    
    J. Desai et al., "Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma", CANCER, 86(9), 1999, pp. 1840-1847
17. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
    Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon
    MEDICAL ONCOLOGY
    
    R.K. Alpaugh et al., "Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon", MED ONCOL, 15(3), 1998, pp. 191-198
18. Sparano, JA; Wiernik, PH; Hu, XP; Sarta, C; Henry, DH; Ratech, H
    Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma
    MEDICAL ONCOLOGY
    
    J.A. Sparano et al., "Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma", MED ONCOL, 15(1), 1998, pp. 50-57
19. SPARANO JA
    USE OF DEXRAZOXANE AND OTHER STRATEGIES TO PREVENT CARDIOMYOPATHY ASSOCIATED WITH DOXORUBICIN-TAXANE COMBINATIONS
    Seminars in oncology
    
    J.A. Sparano, "USE OF DEXRAZOXANE AND OTHER STRATEGIES TO PREVENT CARDIOMYOPATHY ASSOCIATED WITH DOXORUBICIN-TAXANE COMBINATIONS", Seminars in oncology, 25(4), 1998, pp. 66-71
20. Sparano, JA
    Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies
    SEMINARS IN ONCOLOGY
    
    J.A. Sparano, "Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies", SEMIN ONCOL, 25(6), 1998, pp. 10-15
21. ISKAROS BF; HU XP; SPARANO JA; FINEBERG SA
    TENASCIN PATTERN OF EXPRESSION AND ESTABLISHED PROGNOSTIC FACTORS IN INVASIVE BREAST-CARCINOMA
    Journal of surgical oncology
    
    B.F. Iskaros et al., "TENASCIN PATTERN OF EXPRESSION AND ESTABLISHED PROGNOSTIC FACTORS IN INVASIVE BREAST-CARCINOMA", Journal of surgical oncology, 68(2), 1998, pp. 107-112
22. SPARANO JA; HU XP; WIERNIK PH; SARTA C; REDDY D; HANAU L
    OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    J.A. Sparano et al., "OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY", Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 87-87
23. SPARANO JA; WIERNIK PH; HU XP; SARTA C; DOMENECH G; CIOCZEK H; RACEVSKIS J
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS", Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 88-88
24. KABAT GC; CHANG CJ; SPARANO JA; SEPKOVIC DW; HU XP; KHALIL A; ROSENBLATT R; BRADLOW HL
    URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY
    Cancer epidemiology, biomarkers & prevention
    
    G.C. Kabat et al., "URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY", Cancer epidemiology, biomarkers & prevention, 6(7), 1997, pp. 505-509
25. SPARANO JA; NEUBERG D; GLICK JH; ROBERT NJ; GOLDSTEIN LJ; SLEDGE GW; WOOD W
    PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
    Journal of clinical oncology
    
    J.A. Sparano et al., "PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY", Journal of clinical oncology, 15(5), 1997, pp. 1880-1884
26. KABAT GC; CHANG CJ; SPARANO JA; SEPKOVIC DV; HU XP; KHALIL A; ROSENBLATT R; BRADLOW HL
    URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY
    American journal of epidemiology
    
    G.C. Kabat et al., "URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY", American journal of epidemiology, 145(11), 1997, pp. 207-207
27. SPARANO JA; HU XP; WIERNIK PH; SARTA C; REDDY DM; HANAU L; HENRY DH
    OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY
    Journal of the National Cancer Institute
    
    J.A. Sparano et al., "OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY", Journal of the National Cancer Institute, 89(4), 1997, pp. 301-307
28. SPARANO JA; ROBERT N; SILVERMAN P; LAZARUS H; MALIK U; VENKATRAJ U; SARTA C
    PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA
    Journal of clinical oncology
    
    J.A. Sparano et al., "PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA", Journal of clinical oncology, 14(9), 1996, pp. 2576-2583
29. SPARANO JA; WIERNIK PH; HU XP; SARTA C; SCHWARTZ EL; SOEIRO R; HENRY DH; MASON B; RATECH H; DUTCHER JP
    PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA
    Journal of clinical oncology
    
    J.A. Sparano et al., "PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA", Journal of clinical oncology, 14(11), 1996, pp. 3026-3035
30. SPARANO JA; LIPSITZ S; WADLER S; HANSEN R; BUSHUNOW PW; KIRKWOOD J; FLYNN PJ; DUTCHER JP; BENSON AB
    PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292
    American journal of clinical oncology
    
    J.A. Sparano et al., "PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292", American journal of clinical oncology, 19(6), 1996, pp. 546-551
31. ROSENBLATT R; FINEBERG SA; SPARANO JA; KALEYA RN
    STEREOTAXIC CORE NEEDLE-BIOPSY OF MULTIPLE SITES IN THE BREAST - EFFICACY AND EFFECT ON PATIENT-CARE
    Radiology
    
    R. Rosenblatt et al., "STEREOTAXIC CORE NEEDLE-BIOPSY OF MULTIPLE SITES IN THE BREAST - EFFICACY AND EFFECT ON PATIENT-CARE", Radiology, 201(1), 1996, pp. 67-70
32. ISKAROS B; HU X; SPARANO JA; FINEBERG S
    APOPTOSIS IN INVASIVE BREAST-CARCINOMA - CORRELATION WITH GRADE, HORMONE RECEPTORS, AND SURVIVAL
    Laboratory investigation
    
    B. Iskaros et al., "APOPTOSIS IN INVASIVE BREAST-CARCINOMA - CORRELATION WITH GRADE, HORMONE RECEPTORS, AND SURVIVAL", Laboratory investigation, 74(1), 1996, pp. 87-87
33. SENO R; SPARANO JA; FINEBERG S
    DOES NEOADJUVANT CHEMOTHERAPY (NAC) ALTER BIOLOGICAL MARKERS IN LOCALLY ADVANCED BREAST-CANCER (LABC)
    Laboratory investigation
    
    R. Seno et al., "DOES NEOADJUVANT CHEMOTHERAPY (NAC) ALTER BIOLOGICAL MARKERS IN LOCALLY ADVANCED BREAST-CANCER (LABC)", Laboratory investigation, 74(1), 1996, pp. 121-121
34. SENO R; SPARANO JA; FINEBERG S
    GROSS AND HISTOLOGIC FEATURES OF LOCALLY ADVANCED BREAST-CANCER (LABC) AFTER NEOADJUVANT CHEMOTHERAPY (NAC)
    Laboratory investigation
    
    R. Seno et al., "GROSS AND HISTOLOGIC FEATURES OF LOCALLY ADVANCED BREAST-CANCER (LABC) AFTER NEOADJUVANT CHEMOTHERAPY (NAC)", Laboratory investigation, 74(1), 1996, pp. 122-122
35. LEVY RJ; SPARANO JA; KHAN G
    RHABDOMYOLYSIS - AN UNUSUAL COMPLICATION OF CYTOTOXIC CHEMOTHERAPY
    Medical oncology
    
    R.J. Levy et al., "RHABDOMYOLYSIS - AN UNUSUAL COMPLICATION OF CYTOTOXIC CHEMOTHERAPY", Medical oncology, 12(4), 1995, pp. 219-222
36. KHALIL A; CIOBANU N; SPARANO JA; GUCALP R; DUTCHER JP; WIERNIK PH
    PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES
    Bone marrow transplantation
    
    A. Khalil et al., "PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES", Bone marrow transplantation, 15(1), 1995, pp. 93-97
37. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
    ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY
    JAMA, the journal of the American Medical Association
    
    M.A. Cobleigh et al., "ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY", JAMA, the journal of the American Medical Association, 273(8), 1995, pp. 621-621
38. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
    ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994)
    JAMA, the journal of the American Medical Association
    
    M.A. Cobleigh et al., "ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994)", JAMA, the journal of the American Medical Association, 273(5), 1995, pp. 378-378
39. SLEDGE GW; ROBERT N; SPARANO JA; COGLEIGH M; GOLDSTEIN LJ; NEUBERG D; ROWINSKY E; BAUGHMAN C; MCCASKILLSTEVENS W
    EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER
    Seminars in oncology
    
    G.W. Sledge et al., "EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER", Seminars in oncology, 22(3), 1995, pp. 105-108
40. ROSENBLATT R; FEINBERG SA; SPARANO JA; KALEYA RN
    STEREOTAXIC BREAST CORE-NEEDLE BIOPSY OF MULTIPLE SITES - EFFICACY AND IMPACT ON MANAGEMENT
    Radiology
    
    R. Rosenblatt et al., "STEREOTAXIC BREAST CORE-NEEDLE BIOPSY OF MULTIPLE SITES - EFFICACY AND IMPACT ON MANAGEMENT", Radiology, 197, 1995, pp. 407-408
41. SPARANO JA; WIERNIK PH; HU X; DUTCHER JP; SARTA C; HENRY D; MASON B
    DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
    Blood
    
    J.A. Sparano et al., "DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)", Blood, 86(10), 1995, pp. 3724-3724
42. WIERNIK PH; SKLARIN NT; DUTCHER JP; SPARANO JA; GREENWALD ES
    ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER
    Medical oncology
    
    P.H. Wiernik et al., "ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER", Medical oncology, 11(3-4), 1994, pp. 121-125
43. SPARANO JA; OBOYLE K
    IMMUNOLOGICAL THERAPY OF BREAST-CANCER - CURRENT STATUS AND FUTURE POTENTIAL
    CLINICAL IMMUNOTHERAPEUTICS
    
    J.A. Sparano e K. Oboyle, "IMMUNOLOGICAL THERAPY OF BREAST-CANCER - CURRENT STATUS AND FUTURE POTENTIAL", CLINICAL IMMUNOTHERAPEUTICS, 1(2), 1994, pp. 135-147
44. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
    PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
    Journal of immunotherapy with emphasis on tumor immunology
    
    J.A. Sparano et al., "PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS", Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
45. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER NH; SARTA C; CARNEY D; ELKIND R; SHAH M; VALENTINE ES; DUTCHER JP
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
    Leukemia & lymphoma
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN", Leukemia & lymphoma, 14(3-4), 1994, pp. 263-271
46. ATKINS MB; OBOYLE KR; SOSMAN JA; WEISS GR; MARGOLIN KA; ERNEST ML; KAPPLER K; MIER JW; SPARANO JA; FISHER RI; ECKARDT JR; PEREIRA C; ARONSON FR
    MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA
    Journal of clinical oncology
    
    M.B. Atkins et al., "MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA", Journal of clinical oncology, 12(8), 1994, pp. 1553-1560
47. WADLER S; TENTEROMANO L; CAZENAVE L; SPARANO JA; GREENWALD ES; ROZENBLIT A; KALEYA R; WIERNIK PH
    PHASE-II TRIAL OF ECHINOMYCIN IN PATIENTS WITH ADVANCED OR RECURRENT COLORECTAL-CANCER
    Cancer chemotherapy and pharmacology
    
    S. Wadler et al., "PHASE-II TRIAL OF ECHINOMYCIN IN PATIENTS WITH ADVANCED OR RECURRENT COLORECTAL-CANCER", Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 266-269
48. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
    ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE
    JAMA, the journal of the American Medical Association
    
    M.A. Cobleigh et al., "ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE", JAMA, the journal of the American Medical Association, 272(7), 1994, pp. 540-545
49. SLEDGE GW; ROBERT N; SPARANO JA; COBELIGH M; GOLDSTEIN LJ; NEUBERG D; ROWINSKY E; BAUGHMAN C; MCCASKILLSTEVENS W
    PACLITAXEL (TAXOL) DOXORUBICIN COMBINATIONS IN ADVANCED BREAST-CANCER- THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE
    Seminars in oncology
    
    G.W. Sledge et al., "PACLITAXEL (TAXOL) DOXORUBICIN COMBINATIONS IN ADVANCED BREAST-CANCER- THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE", Seminars in oncology, 21(5), 1994, pp. 15-18
50. SPARANO JA; WADLER S; DIASIO RB; ZHANG RW; LU ZH; SCHWARTZ EL; EINZIG A; WIERNIK PH
    PHASE-I TRIAL OF LOW-DOSE, PROLONGED CONTINUOUS-INFUSION FLUOROURACILPLUS INTERFERON-ALFA - EVIDENCE FOR ENHANCED FLUOROURACIL TOXICITY WITHOUT PHARMACOKINETIC PERTURBATION
    Journal of clinical oncology
    
    J.A. Sparano et al., "PHASE-I TRIAL OF LOW-DOSE, PROLONGED CONTINUOUS-INFUSION FLUOROURACILPLUS INTERFERON-ALFA - EVIDENCE FOR ENHANCED FLUOROURACIL TOXICITY WITHOUT PHARMACOKINETIC PERTURBATION", Journal of clinical oncology, 11(8), 1993, pp. 1609-1617
51. SPARANO JA; WIERNIK PH; LEAF A; DUTCHER JP
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY
    Journal of clinical oncology
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY", Journal of clinical oncology, 11(6), 1993, pp. 1071-1079
52. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
    RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA
    Journal of clinical oncology
    
    J.A. Sparano et al., "RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA", Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
53. SPARANO JA; WADLER S; SCHWARTZ EL; DIASIO R
    CLINICAL AND PHARMACOLOGICAL STUDIES OF INTERFERON AND CHEMOTHERAPY IN GASTROINTESTINAL AND BREAST-CANCER
    International journal of clinical pharmacology research
    
    J.A. Sparano et al., "CLINICAL AND PHARMACOLOGICAL STUDIES OF INTERFERON AND CHEMOTHERAPY IN GASTROINTESTINAL AND BREAST-CANCER", International journal of clinical pharmacology research, 13(1), 1993, pp. 1-9
54. SPARANO JA; WADLER S; LIEBES L; ROBERT NJ; SCHWARTZ EL; DUTCHER JP
    PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER
    Cancer research
    
    J.A. Sparano et al., "PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER", Cancer research, 53(15), 1993, pp. 3509-3512
55. SPARANO JA; WIERNIK PH; DUTCHER JP; LEAF A; KHALIL A
    INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT
    Blood
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT", Blood, 82(10), 1993, pp. 10000137-10000137
56. SPARANO JA; WIERNIK PH; DUTCHER JP; SARTA C; STRACK M; LEAF A
    INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
    Blood
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN", Blood, 82(10), 1993, pp. 10000386-10000386
57. CIOBANU N; LAZARUS HM; DEBELLIS R; ASCENSAO J; SPARANO JA; GUCALP R; DUTCHER J; FOX RM; CREGER RJ; COOPER BW; GERSON SL; NESE M; BELLO L; WIEMIK PH
    AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING EX-VIVO ETOPOSIDE(VP-16) PURGED MARROW IN PATIENTS (PTS) WITH POOR-RISK LYMPHOMAS (LY)AND ACUTE LEUKEMIAS (LEUK)
    Blood
    
    N. Ciobanu et al., "AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING EX-VIVO ETOPOSIDE(VP-16) PURGED MARROW IN PATIENTS (PTS) WITH POOR-RISK LYMPHOMAS (LY)AND ACUTE LEUKEMIAS (LEUK)", Blood, 82(10), 1993, pp. 10000629-10000629
58. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER N; VALENTINE ES
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN HUMAN-IMMUNODEFICIENCY-VIRUS CELL AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I RELATEDNON-HODGKINS-LYMPHOMA - A HIGHLY-ACTIVE REGIMEN
    Blood
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN HUMAN-IMMUNODEFICIENCY-VIRUS CELL AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I RELATEDNON-HODGKINS-LYMPHOMA - A HIGHLY-ACTIVE REGIMEN", Blood, 81(10), 1993, pp. 2810-2815